Dataset Information


Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.

ABSTRACT: BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS). We examined a population-based sample of young women with contralateral breast cancer (CBC, n=705) or unilateral breast cancer (UBC, n=1398). We identified 470 unique sequence variants, of which 113 were deleterious mutations. The remaining 357 VUS comprised 185 unique missense changes, 60% were observed only once, while 3% occurred with a frequency of >10%. Deleterious mutations occurred three times more often in women with CBC (15.3%) than in women with UBC (5.2%), whereas combined, VUS were observed in similar frequencies in women with CBC and UBC. A protein alignment algorithm defined 16 rare VUS, occurring at highly conserved residues and/or conferring a considerable biochemical difference, the majority located in the BRCA2 DNA-binding domain. We confirm a multiplicity of BRCA1 and BRCA2 VUS that occur at a wide range of allele frequencies. Although some VUS inflict chemical differences at conserved residues, suggesting a deleterious effect, the majority are not associated with an increased risk of CBC.


PROVIDER: S-EPMC2928257 | BioStudies | 2010-01-01

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3234998 | BioStudies
1000-01-01 | S-EPMC4694828 | BioStudies
2013-01-01 | S-EPMC3660339 | BioStudies
2019-01-01 | S-EPMC7141151 | BioStudies
2018-01-01 | S-EPMC6280886 | BioStudies
2017-01-01 | S-EPMC5939625 | BioStudies
2018-01-01 | S-EPMC5936051 | BioStudies
1000-01-01 | S-EPMC5863854 | BioStudies
2020-01-01 | S-EPMC7448236 | BioStudies
2019-01-01 | S-EPMC6327376 | BioStudies